Schafranek, L
Nievergall, E
Powell, J A
Hiwase, D K
Leclercq, T
Hughes, T P
White, D L
Article History
Received: 27 November 2013
Revised: 14 April 2014
Accepted: 25 April 2014
First Online: 12 May 2014
Competing interests
: Nievergall and Hiwase: CSL, research funding, White: Novartis Oncology, honoraria and research funding; BMS, honoraria and research funding; CSL, research funding; Ariad, research funding, Hughes: Novartis Oncology, honoraria, membership on an entity's Board of Directors or advisory committees and research funding; BMS, honoraria, membership on an entity's Board of Directors or advisory committees and research funding; Ariad, honoraria, membership on an entity's Board of Directors or advisory committees.